Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist

Pathology Results Best Indicate the Course of Breast Cancer

Pathology Results Best Indicate the Course of Breast Cancer

A large proportion of all breast cancers (%89) present at early or locally advanced stages. In early-stage breast cancer, our treatment goals are to completely cure the cancer, reduce the likelihood of cancer recurrence and improve quality of life . Some of our patients with breast cancer need chemotherapy before surgery. This chemotherapy is called neoadjuvant chemotherapy. Its purpose is to shrink the tumor, make it suitable for surgery and improve treatment success. As the tumor shrinks, the success of breast-conserving surgery increases; response to treatment in the axillary lymph nodes will also reduce the likelihood of arm swelling after surgery.

What Is Pathological Complete Response?

The result showing how effective preoperative chemotherapy has been is the pathology result from breast cancer surgery. If no cancer cells are found in the surgical pathology after neoadjuvant treatment, we call this pathological complete response . We knew from previous studies that our patients achieving pathological complete response had a lower likelihood of cancer recurrence. Demonstrating this once again, approximately 28 thousand patients were included in 52 clinical studies, whose meta-analysis was presented at the 2018 San Antonio Breast Cancer Symposium.

What Is a Meta-Analysis? A meta-analysis is a comprehensive investigation combining the results of multiple independent studies on a particular topic and statistically analyzing their findings. Meta-analysis results are the strongest scientific evidence.

According to this comprehensive analysis, breast cancer patients achieving pathological complete response were shown to have a %69 lower cancer recurrence rate. The patients benefiting mostwere those with the breast cancer types triple-negative and HER2-positive breast cancer. In addition, patients deriving complete benefit had a %78 lower mortality (death) rate.

breast cancer 5-Year Overall and Event-Free Survival Rates Pathological Complete Response Residual Disease

In the figure above, you can see how much higher the 5-year overall and event-free survival rates were in patients achieving pathological complete response compared with those with residual disease after surgery.

Conclusion

This study demonstrated the importance of neoadjuvant chemotherapy, particularly in triple-negative and HER2-positive breast cancer. Although it is a valuable study showing the contribution of pathological complete response to our patients, the different chemotherapy drugs used in patients are a limitation of the analysis. We will need to wait for publication of the study article for more detailed information.

Sources

Spring ve ark.
Pathological complete response after neoadjuvant chemotherapy and impact on breast cancer recurrence and mortality, stratified by breast cancer subtypes and adjuvant chemotherapy usage: Individual patient-level meta-analyses of over 27,000 patients.
2018 San Antonio Breast Cancer Symposium, Abstract GS2-03.

Appointment request

DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

Pathology Results Best Indicate the Course of Breast Cancer

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy